Cargando…
Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676547/ http://dx.doi.org/10.1038/sj.bjc.6605004 |
| _version_ | 1782166755758571520 |
|---|---|
| author | Paré, L Marcuello, E Altés, A del Río, E Sedano, L Salazar, J Cortés, A Barnadas, A Baiget, M |
| author_facet | Paré, L Marcuello, E Altés, A del Río, E Sedano, L Salazar, J Cortés, A Barnadas, A Baiget, M |
| author_sort | Paré, L |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2676547 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-26765472010-04-21 Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy Paré, L Marcuello, E Altés, A del Río, E Sedano, L Salazar, J Cortés, A Barnadas, A Baiget, M Br J Cancer Corrigendum Nature Publishing Group 2009-04-21 2009-04-14 /pmc/articles/PMC2676547/ http://dx.doi.org/10.1038/sj.bjc.6605004 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Corrigendum Paré, L Marcuello, E Altés, A del Río, E Sedano, L Salazar, J Cortés, A Barnadas, A Baiget, M Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy |
| title | Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy |
| title_full | Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy |
| title_fullStr | Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy |
| title_full_unstemmed | Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy |
| title_short | Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy |
| title_sort | pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676547/ http://dx.doi.org/10.1038/sj.bjc.6605004 |
| work_keys_str_mv | AT parel pharmacogeneticpredictionofclinicaloutcomeinadvancedcolorectalcancerpatientsreceivingoxaliplatin5fluorouracilasfirstlinechemotherapy AT marcuelloe pharmacogeneticpredictionofclinicaloutcomeinadvancedcolorectalcancerpatientsreceivingoxaliplatin5fluorouracilasfirstlinechemotherapy AT altesa pharmacogeneticpredictionofclinicaloutcomeinadvancedcolorectalcancerpatientsreceivingoxaliplatin5fluorouracilasfirstlinechemotherapy AT delrioe pharmacogeneticpredictionofclinicaloutcomeinadvancedcolorectalcancerpatientsreceivingoxaliplatin5fluorouracilasfirstlinechemotherapy AT sedanol pharmacogeneticpredictionofclinicaloutcomeinadvancedcolorectalcancerpatientsreceivingoxaliplatin5fluorouracilasfirstlinechemotherapy AT salazarj pharmacogeneticpredictionofclinicaloutcomeinadvancedcolorectalcancerpatientsreceivingoxaliplatin5fluorouracilasfirstlinechemotherapy AT cortesa pharmacogeneticpredictionofclinicaloutcomeinadvancedcolorectalcancerpatientsreceivingoxaliplatin5fluorouracilasfirstlinechemotherapy AT barnadasa pharmacogeneticpredictionofclinicaloutcomeinadvancedcolorectalcancerpatientsreceivingoxaliplatin5fluorouracilasfirstlinechemotherapy AT baigetm pharmacogeneticpredictionofclinicaloutcomeinadvancedcolorectalcancerpatientsreceivingoxaliplatin5fluorouracilasfirstlinechemotherapy |